Baseline Requirements for Novel Agents Being Considered for Phase II/III Brain Cancer Efficacy Trials:Conclusions from the Adult Brain Tumor Consortiumâs First Workshop on CNS Drug Delivery
Grossman, Stuart A, Romo, Carlos G, Rudek, Michelle A, Supko, Jeffrey, Fisher, Joy, Nabors, L Burt, Wen, Patrick Y, Peereboom, David M, Ellingson, Benjamin M, Elmquist, William, Barker, Fred G, KamsonJournal:
Neuro-Oncology
DOI:
10.1093/neuonc/noaa142
Date:
June, 2020
File:
PDF, 321 KB
2020
File converter
More search results
More benefits 
